Literature DB >> 23910059

Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine.

Audrey Payancé1, Béatrice Scotto, Jean-Marc Perarnau, Anne de Muret, Yannick Bacq.   

Abstract

BACKGROUND AND AIMS: Severe acute hepatotoxicity is a well known complication following the ingestion of ecstasy (3,4-methylenedioxymethamphetamine [MDMA] ecstasy). Hepatic dysfunction has also been reported after acute cocaine intoxication. However, chronic hepatitis after prolonged use of ecstasy and/or cocaine has rarely been reported.
METHODS: We report the case of a 27-year-old woman hospitalized with edema, ascites and severe liver failure (prothrombin rate 33%), following the use of ecstasy and cocaine over the previous 9 months. Clinical, biological, radiological and pathology findings were recorded at admission and over 8 years' follow-up.
RESULTS: Liver biopsy showed architectural distortion caused by bridging fibrosis, proliferation of cholangioles, and lesions of active interface hepatitis. Other causes of acute and chronic liver disease were excluded. Magnetic resonance imaging showed marked liver fibrosis. After withdrawal of both substances clinical examination and liver function tests progressively normalized. Long-term monitoring with magnetic resonance imaging showed progressive regression of fibrosis.
CONCLUSION: Use of ecstasy and cocaine may cause chronic hepatitis leading to marked liver fibrosis, which may regress after withdrawal of both substances.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23910059     DOI: 10.1016/j.clinre.2013.06.003

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  5 in total

1.  Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.

Authors:  Seth C Kalichman; Christopher Washington; Christopher Kegler; Tamar Grebler; Moira O Kalichman; Chauncey Cherry; Lisa Eaton
Journal:  Subst Use Misuse       Date:  2015-11-19       Impact factor: 2.164

2.  Expression of bax and bcl2 Genes in MDMA-induced Hepatotoxicity on Rat Liver Using Quantitative Real-Time PCR Method through Triggering Programmed Cell Death.

Authors:  Mitra Behroozaghdam; Mehrdad Hashemi; Gholamreza Javadi; Reza Mahdian; Mansoureh Soleimani
Journal:  Iran Red Crescent Med J       Date:  2015-11-26       Impact factor: 0.611

Review 3.  Liver Illness and Psychiatric Patients.

Authors:  Paul Carrier; Marilyne Debette-Gratien; Murielle Girard; Jérémie Jacques; Philippe Nubukpo; Véronique Loustaud-Ratti
Journal:  Hepat Mon       Date:  2016-12-03       Impact factor: 0.660

4.  Reversible Fulminant Hepatitis Secondary to Cocaine in the Setting of β-Blocker Use.

Authors:  Rohan Sharma; Nidhi Kapoor; Kaustubh Suresh Chaudhari; Robert Hal Scofield
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

Review 5.  Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress.

Authors:  Manuela Graziani; Letizia Antonilli; Anna Rita Togna; Maria Caterina Grassi; Aldo Badiani; Luciano Saso
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.